Nifty50 Shariah

Max Healthcare Institute has informed that Nomination and Remuneration Committee (‘NRC’) of the Company in its meeting held today, August 13, 2026, has approved the grant of 3,61,827 stock options to eligible employees under Max Healthcare Institute - Employee Stock Option Scheme 2022. Details pursuant to regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 are enclosed as Annexure. The NRC meeting commenced at 7.50 am (IST) and concluded at 8.20 am (IST). This disclosure will also be hosted on Company's website: ww.maxhealthcare.in.

The above information is a part of company’s filings submitted to BSE. 

With reference to earlier intimations regarding the filing of a ‘short-form’ and subsequently, a ‘long-form’ declaration with the Committee on Foreign Investment in the United States [‘CFIUS’] in connection with the proposed acquisition of AluChem Companies, Inc, Hindalco Industries has informed that due to partial shutdown of the U.S. federal government, the statutory timelines under the CFIUS review framework were tolled, thereby impacting the ongoing CFIUS review process. The matter, however, is progressing and is anticipated to reach finality by September 2, 2026. This timeline remains subject to receipt of final clearance. The company will provide further updates as and when material developments occur or upon completion of the review process. All other details, as per its referred intimations, remain unchanged. This is also made available on the website of the Company www.hindalco.com.